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Site-directed mutagenesis The crystal structure of metagenome-derived LC9-RNase H1 was determined. The structure-based 
mutational analyses indicated that the active site motif of LC9-RN ase H1 is altered from DEDD to 
DEDN. In this motif, the location of the second glutamate residue is moved from aA-helix to 
b1-strand immediately next to the ﬁrst aspartate residue, as in the active site of RNase H2. However, 
the structure and enzymatic properties of LC9-RNase H1 hig hly resemble those of RNase H1, instead 
of RNase H2. We propose that LC9-RNase H1 represents bacterial RNases H1 with an atypical DEDN 
active site motif, which are evolutionarily distinct from those with a typical DEDD active site motif. 
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. 1. Introduction 
Ribonucleas e H (RNase H) is an enzyme that speciﬁcally
degrades the RNA strand of RNA/DNA hybrids [1]. It requires 
divalent cations, such as Mg 2+ and Mn 2+, for catalysis. RNase H is 
widely present in all three kingdoms of living organisms, bacteria, 
archaea and eukarya [2,3]. These RNases H are involved in DNA 
replication, repair and transcriptio n [4–6]. The RNase H domain 
is also an essential part of retroviral reverse transcriptas e (RT),
including human immunodeﬁciency virus type-1 (HIV-1) reverse 
transcriptas e, and is therefore regarded as a target for AIDS therapy 
[7].
RNases H are classiﬁed into two major families, type 1 and type 
2 RNases H, which are represented by RNases H1 and H2, respec- 
tively, based on the differenc e in the amino acid sequence s [2,3].
Despite low amino acid sequence similarity, RNases H1 and H2 
share a main chain fold and steric conﬁgurations of four acidic 
active site residues [3]. Because two metal ions are coordinated by these residues, the scissile phosphate group of the substrate 
and water molecules, a two-metal ion catalysis mechanism has 
been proposed for RNases H [8–10]. According to this mechanis m, 
metal ion A activates the attacking nucleophile , while metal ion B
destabili zes the enzyme–substrate complex and thereby promote s
the hydrolyt ic reaction. 
LC9-RNa se H1 is isolated from the leaf-branch compost by the 
metagen omic approach [11]. LC9-RNase H1 lacks two of the four 
acidic residues that are fully conserved in almost every RNase H1 
sequence and form the active site of these RNases H1. Because 
these four acidic residues are arranged in the order of Asp, Glu, 
Asp, and Asp in almost every RNase H1 sequence, they are 
termed DEDD active site motif [12]. In the amino acid sequence 
of LC9-RNa se H1, the second and fourth residues of this motif 
are replaced by Ala and Asn, respectivel y [11]. Then, the question 
arises whether the steric conﬁgurations of the active site residues 
of LC9-RNa se H1 are different from those of other RNases H1 
with a typical DEDD active site motif. 
In this report, we determined the crystal structure of LC9-RNa se 
H1. Based on the structure-base d mutational analyses, we identi- 
ﬁed four active site residues, including non-conserved glutamate 
and asparagine residues. We propose that LC9-RNa se H1 repre- 
sents bacterial RNases H1 with an atypical DEDN active site motif, 
which are evolutionar ily distinct from those with a typical DEDD 
active site motif. 
Table 1
Data collectio n and reﬁnement statistics. 
Data collection 
Wavelength (Å) 0.9 
Space group P21
Unit cell 
a, b, c (Å) 41.6, 39.9, 50.3 
a, b, c () 90.0, 102.6, 90.0 
Resolution a (Å) 50.00–1.62
(1.65–1.62)
Observations 305 097 
Unique reﬂections 20 537 
Completeness a (%) 99.2 (96.2)
Rmerge
a,b (%) 7.7 (34.9)
Average I/s (I)a 43.6 (4.8)
Reﬁnement statistics 
Resolution limits (Å) 49.04–1.62
Rwork (%) 17.4 
Rfree
c (%) 21.6 




Bond lengths (Å) 0.009 
Bond angles () 1.027 
Overall mean B factors (Å2) 25.89 
Ramachandran analysis (%)
Favored regions 99.04 
Allowed regions 0.96 
a Values in parentheses are for the highest-resolution shell. 
b Rmerge ¼
P j Ihkl—— < Ihkl >j =
P
Ihkl, where Ihkl is the intensity measurement 
for reﬂection with indices hkl and < Ihkl > is the mean intensity for multiply 
recorded reﬂections.
c Rfree was calculated using 5% of the total reﬂections chosen randomly and 
omitted from reﬁnement.
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2.1. Plasmid constructi on, overproduction , and puriﬁcation
Plasmid pET-LC9 for overproduc tion of LC9-RNa se H1 was con- 
structed by amplifying the gene encoding LC9-RNase H1 by PCR 
using pBR322-LC9 [11] as a template and inserted it into the 
NdeI-BamHI sites of pET25b (Novagen) by ligation. Plasmids 
pET-D22A, -E23A, -D96A, -N159A and -N159D for overproduction 
of LC9-D22A, -E23A, -D96A, -N159A and -N159D, respectively ,
were constructed by PCR using the KOD-Plus Mutagenesis kit 
(Toyobo) accordin g to the manufacturer’s instructions. Plasmid 
pET-LC9 was used as a template. All DNA oligomers for PCR were 
synthesized by Hokkaido System Science. PCR was performed with 
a GeneAmp PCR system 2400 (Applied Biosystem s). The DNA 
sequences were conﬁrmed by a Prism 310 DNA sequence r (Applied
Biosystems).
Overproducti on of LC9-RNase H1 and its derivatives using 
Escherichia coli BL21(DE3) transforman ts, disruption of the cells 
by sonicatio n lysis, and centrifugation were performed as 
described previously [13]. The proteins were puriﬁed by cation ex- 
change chromatograp hy using a HiTrap SP column (GE Healthca re)
equilibrated with 20 mM sodium phosphate (pH 6.8), followed by 
hydrophobic interaction chromatography using a Hitrap Phenyl HP 
column (GE Healthcare) equilibrated with 50 mM sodium phos- 
phate (pH 7.0) containing 1 M (NH4)2SO4, and stored in 10 mM 
sodium acetate (pH 4.5).
The purity of the protein was analyzed by SDS–PAGE on a 15% 
polyacrylami de gel [14], followed by staining with Coomassie 
Brilliant Blue. Gel ﬁltration chromatogr aphy was performed using 
a TSK-GEL G3000SW XL column (Sigma–Aldrich) equilibrated with 
50 mM Tris–HCl (pH 7.5) containing 0.5 M NaCl. The protein con- 
centration was determined from UV absorption using an A280 value
of 2.2 for LC9-RNase H1 and its derivatives for a 0.1% (1.0 mg ml 1)
solution. These values were calculated by using e of 1576 M1
cm1 for Tyr and 5225 M1 cm1 for Trp at 280 nm [15].
2.2. Circular dichroism (CD) spectra 
The far-UV CD spectra were measure d on a J-725 spectropol ar- 
imeter (Japan Spectroscopic) at 25 C. The proteins were dissolved 
in 10 mM sodium acetate (pH 4.5). The protein concentr ation and 
optical path length were 0.1 mg ml 1 and 2 mm, respectively . The 
mean residue ellipticity , h, which has the units of deg cm 2 dmol1,
was calculated by using an average amino acid molecula r weight of 
110.
2.3. Enzymatic activity 
The RNase H activity was determined by measuring the amount 
of the acid-soluble digestion product from the substrate, 
3H-labeled M13 DNA/RNA hybrid, accumulated upon incubation 
at 37 C for 15 min, as described previousl y [13]. The reaction mix- 
ture contained 10 mM Tris–HCl (pH 8.5), 10 mM MgCl 2, 10 mM 
NaCl, 1 mM 2-mercapto ethanol, 50 lg ml 1 bovine serum albumin, 
1.0 lM M13 DNA/RNA hybrid (RNA nucleotid e phosphate concen- 
tration), and appropriate amount of enzyme. One unit was deﬁned
as the amount of enzyme producing 1 lmol of acid-soluble mate- 
rial per min. The speciﬁc activity was deﬁned as the enzymatic 
activity per milligram of protein. 
For cleavage of the oligomeri c substrate s, 50-ﬂuorescein-labeled 
12 bp RNA/DNA hybrid (R12/D12), 12 bp RNA/RNA duplex (R12/
R12), 29 bp DNA 15–RNA1–DNA13/DNA duplex (D15–R1–D13/
D29), 29 b RNA and 29 b DNA were prepared as described previ- 
ously [13]. Hydrolysis of the substrate at 37 C for 15 min and separation of the products on a 20% polyacrylamid e gel containing 
7 M urea were carried out as described previously [13]. The prod- 
ucts were detected by Typhoon 9240 Imager (GE Healthcare). The 
reaction buffers were the same as those for the hydrolysis of the 
M13 DNA/RNA hybrid. The products were identiﬁed by comparing 
their migration on the gel. 
2.4. Crystalliz ation 
The crystallizati on conditions were initially screened using 
crystallization kits from Hampton Research (Crystal Screens I and 
II) and Emerald Biostructure s (Wizard I and II). The condition s
were surveyed using sitting-drop vapour-di ffusion method at 
4 C. Drops were prepared by mixing the protein solution at the 
concentr ation of 7 mg ml 1 with the reservoir solution at equal 
volume (1 ll), and were vapour-equilibr ated against 100 ll reser- 
voir solution. Native LC9-RNase H1 crystals appeared after two 
weeks in Crystal Screens II No. 6 (100 mM Tris–HCl pH 8.5, 
200 mM MgCl 26H2O and 30% PEG 4000). The crystallization condi- 
tions were further optimized and crystals were obtained when the 
drop was prepared by mixing 1.5 ll protein solution at the concen- 
tration of 8.5 mg ml 1 with 1 ll reservoir solution (100 mM 
Tris–HCl pH 8.5, 200 mM MgCl 26H2O and 30% PEG 4000) at 4 C.
Crystals grew to ﬁnal size (0.3–0.4 mm) in 6–8 weeks. Since the 
crystal was obtained in the reservoir solution containing 30% PEG 
4000, it was used directly for diffraction data collection without 
further cryoprotect ion. 
2.5. X-ray diffraction data collection and structure determination 
X-ray diffraction data set of LC9-RNase H1 was collected at a
waveleng th of 0.9 Å at 173 C using synchrot ron radiation on 
the BL44XU station at SPring-8 (Hyogo, Japan). The data set was 
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The structure was solved by the molecular replacemen t method 
using MOLREP [17] in the CCP4 program suite. The crystal struc- 
ture of RNase H1 from Sulfolobus tokodaii (Protein Data Bank entry 
2EHG) was used as a starting model. Automatic model building and 
also automatic placement of water molecules were then done 
using Arp/wArp [18], followed by manually checking on correct 
assignment . Iteration between model reﬁnement using REFMAC5 
[19] and manual adjustment s using Coot [20] was done until no 
further decrease of the Rfree was observed. The statistics for data 
collection and reﬁnement are summari zed in Table 1. The ﬁgures
were prepared using PyMol (http://www. pymol.org ).
2.6. Protein Data Bank accession number 
The coordinates and structure factors for LC9-RNase H1 have 
been deposited in the Protein Data Bank under accession code 4IBN. 
3. Results and discussion 
3.1. Protein preparation 
Upon overproduc tion, LC9-RNa se H1 accumulated in the cells in 

























Fig. 1. Crystal structure of LC9-RNase H1. (A) Stereoview of the structure of LC9-RNase H1
RNase H1 structures are colored brown and grey, respectively. Five active site residues of
Glu48, Asp70, His124, and Asp134) are shown by stick models, in which the oxygen and
RNase H1 (Gln169-Ser220) is colored green. NT and CT represent N- and C-termini. (B) S
residues of LC9-RNase H1 (brown) and Ec-RNase H1 (grey) are superimposed onto thos
metal ions (slate, PDB code 2QKK). The positions of the RNA strand of the substrate wit(data not shown). The amount of LC9-RNase H1 puriﬁed from 1 L of 
culture was approximat ely 3 mg. The molecula r mass of LC9-RNa se 
H1 was estimate d to be 24 kDa by SDS–PAGE and 21 kDa by gel 
ﬁltration chromatography . These values are comparable to that 
calculated from the amino acid sequence (23.8 kDa), indicating 
that LC9-RNase H1 exists in a monomeric form, like other type 1
RNases H1. 
3.2. Crystal structure 
The crystal structure of LC9-RNa se H1 was determined at a res- 
olution of 1.6 Å. The N-terminal nine residues are not visible in the 
electron density map, possibly due to a structural disorder. Details 
of the data-collect ion statistics and reﬁnement are summarized in 
Table 1. The overall structure of LC9-RNase H1 is highly similar to 
that of E. coli RNase H1 (Ec-RNase H1) (PDB code 1RNH) with the 
root-mea n-square deviation (RMSD) value of 1.50 Å for 127 Ca
atoms (Fig. 1A). It shares a ﬁve-stranded mixed b-sheet with three 
antiparall el (b1, b2 and b3) and two parallel (b4 and b5) b-strands
and ﬁve a-helices (aA, aB, aC, aD and aE) with Ec-RNase H1. How- 
ever, LC9-RNase H1 has a longer C-terminal tail than Ec-RNase H1. 
This tail (Gln169-Ser220), which is extended from the C-terminus 
of aE-helix and contains two additional helices (aF and aG), is 























 superimposed on that of Ec-RNase H1 (PDB code 1RNH). The LC9-RNase H1 and Ec- 
 LC9-RNase H1 (Asp22, Glu23, Asp96, His149, and Asn159) and Ec-RNase H1 (Asp10,
 nitrogen atoms are colored red and blue, respectively. The C-terminal tail of LC9- 
tereoview of the active site structures of RNases H. The side chains of the active site 
e in the cocrystal structure of Hs-RNase HC with the 14 bp RNA/DNA substrate and 
h the scissile phosphate group and two metal ions A and B are also shown. 
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β1 β 2
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Fig. 2. Alignment of the amino acid sequences. The amino acid sequences of LC9-RNase H1 (LC9), Ec-RNase H1 (Ec), and Hs-RNase HC (Hs) are compared with one another on 
the basis of their crystal structures. The ranges of the secondary structures of LC9-RNase H1 and Ec-RNase H1 are shown above and below the sequences, respectively. The 
amino acid residues that are conserved in at least two different proteins are highlighted in light grey. The second glutamate residues of a DEDN or DEDD active site motif are 
highlighted in cyan, and the other four active site residues are highlighted in yellow. The amino acid residues that contact the RNA and DNA strands of the substrate in the 
cocrystal structure of Hs-RNase HC with the substrate are indicated by the open and closed circles above the sequences, respectively. Gaps are denoted by dashes. The 
numbers represent the positions of the amino acid residues relative to the initiator methionine for each protein. 
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through hydrogen bonds and hydrophobic interactions . According 
to a model of the LC9-RNase H1-substrat e complex constructed 
based on the structure of the catalytic domain of human (Homo
sapiens) RNase H1 (Hs-RNase HC) in complex with the substrate 
[21] suggests that RNA/DNA hybrid binds to the protein such that 
the RNA strand contacts the active site and the DNA strand con- 
tacts aC-helix and the following loop. Because, the C-terminal tail 
is apparently located far from the substrate binding site, it may not 
be important for enzymatic activity. However, further mutational 
and structural studies will be required to understand the role of 
this tail. 
The amino acid sequence of LC9-RNa se H1 is compared with 
those of Ec-RNase H1 and Hs-RNase HC on the bases of their crystal 
structures in Fig. 2. The sequence of LC9-RNase H1 is 37.4% and 
31.8% identical to those of Ec-RNase H1 and Hs-RNase HC, 
respectively .
3.3. Active site 
The four conserved acidic residues (Asp10, Glu48, Asp70, and 
Asp134 for Ec-RNase H1, and Asp145, Glu186, Asp210, and 
Asp274 for Hs-RNase HC) form the active sites of Ec-RNase H1 
and Hs-RNase HC [21]. In contrast, the two conserved acidic resi- 
dues, Asp22 and Asp96, one non-conserved glutamate residue 
(Glu23), and one non-conserved asparagines residue (Asn159)
form the active site of LC9-RNa se H1 (Figs. 1A and 2). Superimpo- 
sition of the active site structures of LC9-RNase H1 and Ec-RNase 
H1 on the cocrystal structure of Hs-RNase HC with the substrate 
and metal cofactors [21] indicates that the steric conﬁgurations
of the four active site residues of LC9-RNase HI are very similar 
to those of Ec-RNase H1 and Hs-RNase HC (Fig. 1B). Therefore, 
these four residues of LC9-RNa se H1 probably form the metal bind- 
ing sites A and B, as seen in the cocrystal structure of Hs-RNase HC. 
In addition, His149 of LC9-RNa se H1 is located at the similar posi- 
tion where His124 of Ec-RNase H1 and His264 of Hs-RNase HC are 
located (Fig. 1B). This residue may facilitate product release by dis- 
lodging the 50-phosphate, as proposed for His264 of Hs-RNase HC 
[21]. It is noted that the ﬁrst and second active site residues of LC9-RNa se H1 (Asp22 and Glu23) are located adjacentl y in the 
same b-strand (b1), whereas the correspond ing residues of 
Ec-RNase H1 (Asp10 and Glu48) and Hs-RNase HC (Asp145 and 
Glu186) are located distantly in b1-strand and aA-helix,
respectively (Fig. 2). Similar arrangement of the active site residues 
is also observed in the amino acid sequences of RNases H2, in 
which the ﬁrst (Asp) and second (Glu) active site residues are 
located adjacently in the same b-strand [2,22]. However the steric 
conﬁgurations of the active site residues of LC9-RNase H1 are more 
similar to those of RNases H1 than to those of RNases H2. 
3.4. Enzymati c activity of LC9-RNase H1 
The optimum condition for activity of LC9-RNa se H1 was ana- 
lyzed at 37 C by changing one of the conditions used for assay 
[10 mM Tris–HCl (pH 8.5), 10 mM NaCl, and 10 mM MgCl 2]. The 
M13 DNA/RNA was used as a substrate . LC9-RNase H1 exhibited 
activity at the wide pH range between 6 and 11 with the maximum 
at pH 10 (Fig. S1 in Supplement ary data ), like Ec-RNase H1 [23,24].
Neverthel ess, the activity was determined at pH 8.5, at which 
LC9-RNa se H1 exhibits approximately 80% of the maximal activity, 
because the stability of the substrate and the solubility of the metal 
cofactor decrease as the pH increases beyond 9.0. LC9-RNase H1 
preferred Mg 2+ to Mn 2+ ions for activity (Fig. S2 in Supplement ary 
data), like Ec-RNase H1 [24]. It exhibited maximal activity at 
10 mM MgCl 2 and 0.1 mM MnCl 2. The speciﬁc activities of 
LC9-RNa se H1 and Ec-RNase H1 were determined to be 4.3 and 
12 units/mg, respectively , in the presence of 10 mM MgCl 2, and 
0.4 and 1.1 units/mg, respectively, in the presence of 0.1 mM 
MnCl2.
The substrate and cleavage-site speciﬁcities of LC9-RNase H1 
were analyzed by using 12 bp RNA/DNA hybrid (R12/D12), 12 bp 
RNA/RNA duplex (R12/R12), 29 b RNA, 29 b DNA, and 29 bp 
DNA15–RNA1–DNA13/DNA duplex (D15–R1–D13/D29), and com- 
pared with those of Ec-RNase H1. D15-R1-D13 is a 29 b DNA con- 
taining a single ribonucleoti de. LC9-RNa se H1 cleaved the R12/D12 
substrate at multiple sites, most preferably at a9–c10, in the pres- 
ence of 10 mM MgCl 2, as did Ec-RNase H1 (Fig. 3). Both enzymes 
did not cleave other substrates (data not shown), indicating that 
Table 2
Speciﬁc activities of LC9-RNase H1 and its variants. a
Protein Metal Speciﬁc activity (U/mg) Relative activity b (%)
LC9-RNase H1 MgCl 2 4.30 100 
MnCl 2 0.40 100 
LC9-D22A MgCl 2 <4  104 <0.01% 
MnCl 2 <4  104 <0.1% 
LC9-E23A MgCl 2 <4  104 <0.01% 
MnCl 2 <4  104 <0.1% 
LC9-D96A MgCl 2 <4  104 <0.01% 
MnCl 2 <4  104 <0.1% 
LC9-N159A MgCl 2 0.11 2.6 
MnCl 2 0.08 20 
LC9-N159D MgCl 2 0.72 17 
MnCl 2 0.02 5.0 
a The enzymatic activity was determined at 37 C and pH 8.5 in the presence of 
10 mM MgCl 2 or 0.1 mM MnCl 2 using M13 DNA/RNA hybrid as a substrate. The 
experiment was carried out at least twice. Errors, which represent the 67% conﬁ-
dence limits, are all at or below ±20% of the values reported. 
b The Mg 2+- and Mn 2+-dependent speciﬁc activities of the LC9-RNase H1 variants 
relative to those of LC9-RNase H1. 
A LC9-RNase H1 Ec-RNase H1
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Fig. 3. Cleavage of the 12 bp RNA/DNA substrate with LC9-RNase H1 and Ec-RNase H1. (A) Separation of the hydrolysates by urea gel. The 50-end labeled 12 bp RNA/DNA 
substrate was hydrolyzed by the enzyme in the presence of 10 mM MgCl 2 at 37 C for 15 min and the hydrolysates were separated on a 20% polyacrylamide gel containing 
7 M urea. The concentration of the substrate was 1.0 lM. The enzyme is indicated above each lane together with its concentration in the reaction mixture. The sequence of the 
RNA strand of the substrate is indicated along the gel. (B) Schematic representation of the sites and extents of cleavage by LC9-RNase H1 and Ec-RNase H1. Cleavage sites are 
shown by arrows. The differences in the lengths of the arrows reﬂect relative cleavage intensities at the position indicated. These lengths do not necessarily reﬂect the amount 
of the products accumulated upon complete hydrolysis of the substrate. 
1422 T.-N. Nguyen et al. / FEBS Letters 587 (2013) 1418–1423they do not cleave double-strand ed DNA (dsDNA), single ribonu- 
cleotide-embe dded dsDNA, dsRNA, and single-st randed RNA and 
DNA. Thus, the enzymatic properties of LC9-RNase H1 are similar 
to those of Ec-RNase H1, although its speciﬁc activity is lower than 
that of Ec-RNase H1 by three-fold. 
3.5. Mutation of active site residues 
To examine whether all four active site residues are required for 
activity of LC9-RNa se H1, we constructed the four mutant proteins, 
LC9-D22A, LC9-E23A, LC9-D96A, and LC9-N159A, in which Asp22, 
Glu23, Asp96, and Asn159 are replaced by Ala, respectively. The 
far-UV CD spectra of all mutant proteins were nearly identical with 
that of LC9-RNase H1, indicating that none of the mutations does 
not signiﬁcantly affect the tertiary structure of the protein 
(Fig. S3 in Supplement ary data ). The enzymatic activities of these 
mutant proteins are summarized in Table 2. LC9-D22A, LC9- 
E23A, and LC9-D96A exhibited the background level of activity 
either in the presence of Mg 2+ or Mn 2+ ions, indicating that 
Asp22, Glu23, and Asp96 are required for activity. These residues 
are probably required for coordina tion with metal ion A and/or 
metal ion B. LC9-N159A also exhibited greatly decrease d activity, 
but retained 2.6% and 20% of the activity of LC9-RNase H1 in the 
presence of Mg 2+ and Mn 2+ ions, respectivel y, indicating that 
Asn159 is important for activity but is not required for activity. 
Dispensabili ty of the corresponding aspartate residues for activity 
has been reported for several RNases H1 [12,22].
In addition to the mutant proteins mentioned above, the mu- 
tant protein LC9-N159D was constructed to examine whether the 
mutation of the fourth active site residue (Asn159) to Asp increases 
the activity of LC9-RNase H1. The far-UV CD spectrum of LC9- 
N159D was similar to that of LC9-RNase H1, indicating that the 
mutation does not signiﬁcantly affect the protein structure 
(Fig. S3 in Supplementary data ). However, LC9-N159D exhibited 
17 and 5% of the activity of LC9-RNase H1 in the presence of 
Mg2+ and Mn 2+ ions, respectivel y (Table 2). The mutation greatly 
reduces the activity, probably because it causes a subtle conforma- 
tional change, which is unfavorable for activity, around the active site. Thus, LC9-RNase H1 probably uses Asn as the fourth active site 
residue to avoid of this unfavorable conformati onal change. 
3.6. LC9-RNase H1 homologues 
Identiﬁcation of Asp22, Glu23, Asp96, and Asn159 as the active 
site residues of LC9-RNase H1 indicates that LC9-RNase H1 has an 
atypical DEDN active site motif, in which the ﬁrst and second res- 
idues are consecutive and the fourth acidic residue of a typical 
DEDD active site motif is replaced by Asn. Database searches indi- 
cate that LC9-RNase H1 is not the only enzyme with this motif. 
RNase H1 from Gemmatimon as aurantiaca (Gau-RNase H1) (acces-
sion No. C1A5K0), which shows the amino acid sequence identity 
of 55% to LC9-RNa se H1, also has this motif [11]. Phylogenetic anal- 
ysis using representat ive members of bacterial RNases H1 indicates 
that a common ancestor of LC9-RNase H1 and Gau-RNa se H1 is di- 
verged from that of all bacterial RNases H1 before all other bacte- 
T.-N. Nguyen et al. / FEBS Letters 587 (2013) 1418–1423 1423rial RNases H1 are diverged from it [11]. Because G. aurantiaca is a
representat ive member of the bacterial phylum Gemmatimonadet es 
newly identiﬁed recently [25], LC9-RNase H1 and its homologues 
with an atypical DEDN active site motif may be functionally closely 
related to, but evolutionarily distantly related to other RNases H1 
with a typical DEDD active site motif. 
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